sulmazole has been researched along with Shock, Cardiogenic in 1 studies
sulmazole: structure given in first source
sulmazole : An imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardiotonic agent.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effect of sulmazol was greater than the effect of an increased dosage of dobutamine in five patients in whom this was studied." | 1.27 | Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock. ( Hugenholtz, PG; Muskens, G; Simoons, ML, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simoons, ML | 1 |
| Muskens, G | 1 |
| Hugenholtz, PG | 1 |
1 other study available for sulmazole and Shock, Cardiogenic
| Article | Year |
|---|---|
Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock.
Topics: Adult; Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Female; | 1983 |